Acadia Pharmaceuticals Inc

VICTORY CAPITAL MANAGEMENT INC ACAD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

177,605

Value ($000)

4,744

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	4,744	0.0%	177,605	12/31/2025
2025 Q3	11/12/2025	5,144	0.0%	241,071	9/30/2025
2025 Q2	8/13/2025	2,893	0.0%	134,142	6/30/2025
2025 Q1	5/2/2025	2,535	0.0%	152,646	3/31/2025
2024 Q4	2/6/2025	2,975	0.0%	162,125	12/31/2024
2024 Q3	11/5/2024	1,494	0.0%	97,130	9/30/2024
2024 Q2	8/5/2024	1,534	0.0%	94,422	6/30/2024
2024 Q1	5/3/2024	1,474	0.0%	79,722	3/31/2024
2023 Q4	2/5/2024	3,079	0.0%	98,353	12/31/2023
2023 Q3	11/6/2023	2,075	0.0%	99,565	9/30/2023
2023 Q2	7/27/2023	1,872	0.0%	78,171	6/30/2023
2023 Q1	5/2/2023	1,479	0.0%	78,580	3/31/2023
2022 Q4	4/25/2023	1,171	0.0%	73,548	12/31/2022
2022 Q3	11/2/2022	295	0.0%	18,009	9/30/2022
2022 Q2	8/1/2022	259	0.0%	18,369	6/30/2022
2022 Q1	5/4/2022	335	0.0%	18,189	3/31/2022
2021 Q4	2/7/2022	431	0.0%	18,475	12/31/2021
2021 Q3	11/2/2021	316	0.0%	19,036	9/30/2021
2021 Q2	8/3/2021	517	0.0%	21,202	6/30/2021
2021 Q1	5/4/2021	590	0.0%	22,874	3/31/2021
2020 Q4	2/1/2021	1,153	0.0%	21,572	12/31/2020
2020 Q3	11/9/2020	967	0.0%	23,434	9/30/2020
2020 Q2	8/7/2020	1,100	0.0%	22,703	6/30/2020
2020 Q1	5/4/2020	959	0.0%	22,708	3/31/2020
2019 Q4	2/6/2020	971	0.0%	22,688	12/31/2019